KalshiFerméVérifier la disponibilitéKYC requisDonnées de résolution vérifiéesBien calibréCe marché s'est résolu: Dazodalibep (99%)
Preuves de résolution limitées
CoinRithm peut afficher le résultat enregistré, mais tous les champs de règlement ne sont pas vérifiés par le fournisseur.
Alerte qualité des donnéesDonnées obsolètes
Données au 3 nov. 2026, 23:45 UTC · politique pm-quality-4
Chronologie des Probabilités
Dazodalibep90%
Eosinophilic92%
ESMO0%
Imfinzi / Durvalumab99%
GLP-1 / GLP89%
Medicare96%
Patent (2+ times)89%
Litigation27%
Artificial Intelligence (3+ times)0%
Buyback / Buy Back0%
Tavneos90%
Prolia (2+ times)90%
Oral (3+ times)0%
Acquisition0%
DazodalibepGagné
EosinophilicPerdu
ESMOPerdu
Imfinzi / DurvalumabPerdu
GLP-1 / GLPPerdu
MedicarePerdu
Patent (2+ times)Perdu
TavneosPerdu
Prolia (2+ times)Perdu
LitigationPerdu
Artificial Intelligence (3+ times)Perdu
Buyback / Buy BackPerdu
Oral (3+ times)Perdu
AcquisitionPerdu
Marchés Associés
Questions liées pour le contexte, et non une comparaison de contrats équivalents.
Règles
If Dazodalibep is said by any Amgen representative (including the operator of the call) during the next Amgen live earnings call or official broadcast (including the Q+A), then the market resolves to Yes.
Règlement via:Amgen Investor Relations
- How this is resolved Video of Amgen earnings call. If a consensus by Kalshi employees cannot be reached using video, transcripts of Amgen earnings call will be used according to the news publications listed in the contract. Payout criteria The exact phrase/word, or a plural or possessive form of the phrase/word. Doesn't count for payout Grammatical/tense inflections. Kalshi is not affiliated, associated, authorized, endorsed by, or in any way officially connected with the Amgen corporation. All trademarks, logos, and brand names are the property of their respective owners.
Règles de chaque résultat
- Dazodalibep
- If Dazodalibep is said by any Amgen representative (including the operator of the call) during the next Amgen live earnings call or official broadcast (including the Q+A), then the market resolves to Yes.
- Eosinophilic
- If Eosinophilic is said by any Amgen representative (including the operator of the call) during the next Amgen live earnings call or official broadcast (including the Q+A), then the market resolves to Yes.
- ESMO
- If ESMO is said by any Amgen representative (including the operator of the call) during the next Amgen live earnings call or official broadcast (including the Q+A), then the market resolves to Yes.
- Imfinzi / Durvalumab
- If Imfinzi / Durvalumab is said by any Amgen representative (including the operator of the call) during the next Amgen live earnings call or official broadcast (including the Q+A), then the market resolves to Yes.
- GLP-1 / GLP
- If GLP-1 / GLP is said by any Amgen representative (including the operator of the call) during the next Amgen live earnings call or official broadcast (including the Q+A), then the market resolves to Yes.
- Medicare
- If Medicare is said by any Amgen representative (including the operator of the call) during the next Amgen live earnings call or official broadcast (including the Q+A), then the market resolves to Yes.
- Patent (2+ times)
- If Patent (2+ times) is said by any Amgen representative (including the operator of the call) during the next Amgen live earnings call or official broadcast (including the Q+A), then the market resolves to Yes.
- Tavneos
- If Tavneos is said by any Amgen representative (including the operator of the call) during the next Amgen live earnings call or official broadcast (including the Q+A), then the market resolves to Yes.
- Prolia (2+ times)
- If Prolia (2+ times) is said by any Amgen representative (including the operator of the call) during the next Amgen live earnings call or official broadcast (including the Q+A), then the market resolves to Yes.
- Litigation
- If Litigation is said by any Amgen representative (including the operator of the call) during the next Amgen live earnings call or official broadcast (including the Q+A), then the market resolves to Yes.
- Artificial Intelligence (3+ times)
- If Artificial Intelligence (3+ times) is said by any Amgen representative (including the operator of the call) during the next Amgen live earnings call or official broadcast (including the Q+A), then the market resolves to Yes.
- Buyback / Buy Back
- If Buyback / Buy Back is said by any Amgen representative (including the operator of the call) during the next Amgen live earnings call or official broadcast (including the Q+A), then the market resolves to Yes.
- Oral (3+ times)
- If Oral (3+ times) is said by any Amgen representative (including the operator of the call) during the next Amgen live earnings call or official broadcast (including the Q+A), then the market resolves to Yes.
- Acquisition
- If Acquisition is said by any Amgen representative (including the operator of the call) during the next Amgen live earnings call or official broadcast (including the Q+A), then the market resolves to Yes.